![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of the Xpert fingerstick HCV viral load assay
|
|
|
Reported by Jules Levin
EASL April 2018 Paris France
F. Lamoury1,2, S. Bajis1, B. Hajarizadeh1, A. Marshall1, M. Martinello1, E. Ivanova2, B. Catlett3, Y.Mowat1, P. Marks1, J. Amin4, J. Smith5,
N. Ezard6, V. Cock7, J. Hayllar8, D. Persing9, M. Kleman10, P. Cunningham11, G. Dore1, T. Applegate1, J. Grebely12. 1UNSW Sydney,
The Kirby Institute, Sydney, Australia; 2Foundation for Innovative Diagnostics, Geneva, Switzerland; 3St Vincent's Centre for Applied
Medical Research, Sydney, Australia; 4Macquarie University, Sydney, Australia; 5Matthew Talbot Hostel, St Vincent de Paul Society NSW
Support Services, Sydney, Australia; 6St Vincent's Hospital, Alcohol and Drug Service, Sydney, Australia; 7Drug and Alcohol Services of South
Australia, Adelaide, Australia; 8Metro North Mental Health, Metro North Hospital and Health Service, Alcohol and Drug Service, Brisbane,
Australia; 9Cepheid, Sunnyvale, United States; 10Cepheid AB, Solna, Sweden; 11St Vincent's Centre for Applied Medical Research, Sydney,
Australia; 12UNSW Sydney, The Kirby Institute, Australia
Email: jgrebely@kirby.unsw.edu.au
![AASDL1](../images%20/060718/060718-5/AASDL1.gif)
![AASDL2](../images%20/060718/060718-5/AASDL2.gif)
![AASDL3](../images%20/060718/060718-5/AASDL3.gif)
![AASDL4](../images%20/060718/060718-5/AASDL4.gif)
![AASDL5](../images%20/060718/060718-5/AASDL5.gif)
![AASDL6](../images%20/060718/060718-5/AASDL6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|